Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Combining pulsed radiofrequency and platelet-rich plasma for treating facial pain

Official title: Effectiveness and Safety of Platelet-Rich Plasma Combined With Pulsed Radiofrequency to Treat Patients With Infraorbital Neuralgia

Run by Beijing Tiantan Hospital · NCT06492213 · Data updated 2026-11-12

This study is testing whether combining a special type of injection with a new pain treatment can help people with stubborn facial pain who haven't found relief from other methods.

More Platelet Rich Plasma trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment240 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedJuly 1, 2026
Study endsJuly 1, 2027
Registry record updatedFebruary 21, 2025
Trial IDNCT06492213 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 75 with severe infraorbital neuralgia who have not found relief from standard treatments.

Probably not a fit

Patients with certain blood disorders, severe organ dysfunction, or a history of destructive treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective, observational study aims to evaluate the effectiveness and safety of combining platelet-rich plasma (PRP) injections with pulsed radiofrequency (PRF) treatment for patients suffering from refractory infraorbital neuralgia (IONa). The study focuses on individuals who have not responded well to conventional therapies and are seeking a minimally invasive treatment option. Participants will be assessed for pain relief and safety outcomes, with a particular emphasis on those reluctant to undergo more destructive therapies. The study employs a propensity score matching approach to ensure balanced comparisons between treatment groups.

Why it matters

Potential benefit: If successful, this approach could provide a new, effective, and minimally invasive treatment option for patients suffering from refractory infraorbital neuralgia.

How similar studies have gone: While the efficacy of pulsed radiofrequency has been previously established, the combination with platelet-rich plasma for this specific condition is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 to 75 years;
2. Paroxysmal or persistent stabbing pain in the distribution area of the infraorbital nerve and positive response to diagnostic block (1 ml of 2% lidocaine) prior to treatment;
3. NRS score≥7;
4. Scheduled for PRF treatment for IONa;
5. Signed informed consent.

Exclusion Criteria:

1. Platelet count \<105\*109/L, ongoing anticoagulation therapy or antiplatelets treatment, coagulation disorders or bleeding disorders;
2. Severe cardiopulmonary or hepatorenal dysfunction;
3. Infection at the puncture site; .
4. Neuralgia secondary to tissue damage around the infraorbital foramen from causes such as maxillary sinusitis or tumor;
5. History of destructive treatments such as radiofrequency thermocoagulation, chemical ablation, infraorbital neurectomy, infraorbital nerve avulsion, etc;
6. History of mental disorders;
7. History of narcotic drug abuse;
8. Unable to cooperation.

Where it's running

  • Fang Luo
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.